D D Sharma of Risk Capital Advisors is of the view that one should buy Biocon.
D D Sharma of Risk Capital Advisors is of the view that one should buy Biocon .
Sharma told CNBC-Awaaz, "One can accumulate Biocon with a stoploss of Rs 229. The stock can touch level of Rs 255 in medium term."
The company touched its 52-week high Rs 382.00 and 52-week low Rs 225.75 on 20 Jul, 2011 and 27 Apr, 2012, respectively.
Set email alert for
ADS BY GOOGLE
video of the day
No definite plans for merger of PSU banks: Banking Secy